Alberta’s controversial approach to the opioid crisis rejects harm reduction, including supervised consumption sites. Despite recent UCP claims that the program is working, more evidence is needed.
Academic rigour, journalistic flair
Articles on Overdose
Displaying 1 - 20 of 57 articles
Cocaine and other illicit drugs have been found to be contain nitazenes, a dangerous class of synthetic opioids.
The toxic drug crisis is not only about fatalities. A much larger number of people survive overdoses, and are left with brain injuries. A national strategy to support and treat them is crucial.
Decriminalizing drugs is not intended as a solution to drug problems. Rather, it is a critical first step that’s necessary, but not sufficient, for replacing prohibition with a public health approach.
Some viewers seem to want Abela’s voice to be a carbon copy of Winehouse’s. But the art of vocal impersonation isn’t about perfect replication.
Long-acting injectable buprenorphine is also known by the brand names Buvidal or Sublocade.
Drug checking services could also provide an early warning system to flag any unusually dangerous substances in circulation.
Nitazenes were developed as a powerful class of painkiller in the 1950s, but they were abandoned – until now.
A police policy of not making arrests for simple possession is a way to essentially decriminalize personal drug use. However, confiscating drugs — even without arrests — can be harmful in many ways.
The US has seen a huge rise in drug deaths in the past decade involving a stimulant and a depressant.
Most consumables in Canada have quality controls that inform purchasing and consumption decisions. People who use illicit drugs deserve the same. Drug checking provides that harm-reduction service.
Harm reduction is grounded in evidence. But policies, stigma and ignorance about substance use still create barriers in battling Canada’s drug poisoning crisis.
Unlike opioid drugs like morphine and fentanyl that travel throughout the body, the opioids your body produces are released in small quantities to specific locations.
Acetaminophen is one of the most commonly used drugs, yet acetaminophen overdose is a leading cause of liver damage. It can be easily prevented.
Xylazine, or tranq, is increasingly being mixed with drugs like fentanyl or heroin and can be difficult to detect. Most people who use drugs are unable to tell if they have been exposed to it.
From ‘Breaking Bad’ to James Bond, certain chemicals are popular options for characters looking to achieve nefarious ends.
More than 50 overdoses happen in bathrooms every month in British Columbia. Public bathrooms can be made safer for everyone, including people who use substances.
Australians bought more than 65 million packs of paracetamol pain relief last year. TGA efforts to reduce its potential harms will need to take those who use it to manage pain into consideration.
Fentanyl’s wide availability in the drug supply has led to an increase in unintentional overdoses. While prevention strategies are available, limited availability stymies their use.
We researched how much difference opioids like codeine, oxycodone or morphine make to osteoarthritis pain. We found they helped about as much as paracetamol. Yet they are far more dangerous.
Top contributors
-
Professor and Director - Academic Excellence, Macquarie University
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Vice Chancellor’s Senior Research Fellow, Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University
-
Professor of Emergency Medicine, UMass Chan Medical School
-
PhD Candidate, School of Nursing, University of British Columbia
-
Professor of Neuropharmacology, University of Central Lancashire
-
Professor at the National Drug & Alcohol Research Centre, UNSW Sydney
-
Associate Professor of Criminology, Edinburgh Napier University
-
Senior Research Fellow, School of Health and Life Sciences, Glasgow Caledonian University
-
Executive Clinical Director, Turning Point & Director of Monash Addiction Research Centre, Monash University
-
Addiction Psychiatrist, Associate Professor, Monash University
-
Palliative Medicine Physician, Senior Research Fellow, The University of Melbourne
-
Research Scientist, BC Centre on Substance Use and Assistant Professor, Department of Sociology, University of British Columbia
-
Conjoint Senior Lecturer, National Drug and Alcohol Research Centre, UNSW Sydney
